申请人:YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD.
公开号:EP0596125A1
公开(公告)日:1994-05-11
A condensed thiophene compound represented by general formula (I) or a pharmaceutically acceptable salt thereof, wherein ring S represents a thiophene ring; R1 represents hydrogen, halogen, alkyl, etc.; R2 represents hydrogen, alkyl, acyl, etc.; G represents -CH2-, -CH(OH)-, -CO-, etc. Q represents alkylene; T represents - NH2, -NHRa (wherein Ra represents alkyl, cycloalkyl, etc.) or -NRbRc (wherein Rb and Rc represent each alkyl, etc., or alternatively Rb and Rc are combined together to form cyclic amino); D represents -CH2- or -S-; A and B represent each carbonyl or thiocarbonyl, or are null; and m and n represent each 0, 1 to 4, provided that m + n represents an integer of 4 or less. This compound is useful as an antipsychotic drug having a reduced extrapyramidal side effect or an antianxiety drug.
通式(I)代表的缩合噻吩化合物或其药学上可接受的盐,其中环 S 代表噻吩环;R1 代表氢、卤素、烷基等;R2 代表氢、烷基、酰基等;G 代表-CH2-、-CH(OH)-、-CO-等。Q代表亚烷基;T代表-NH2、-NHRa(其中Ra代表烷基、环烷基等)或-NRbRc(其中Rb和Rc分别代表烷基等,或Rb和Rc组合在一起形成环氨基);D代表-CH2-或-S-;A和B分别代表羰基或硫代羰基,或为空;m和n分别代表0、1至4,条件是m+n代表4或更小的整数。这种化合物可用作具有减轻锥体外系副作用的抗精神病药物或抗焦虑药物。